Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma

Caixia Cheng,Yong Zhou,Hongyi Li,Teng Xiong,Shuaicheng Li,Yanghui Bi,Pengzhou Kong,Fang Wang,Heyang Cui,Yaoping Li,Xiaodong Fang,Ting Yan,Yike Li,Juan Wang,Bin Yang,Ling Zhang,Zhiwu Jia,Bin Song,Xiaoling Hu,Jie Yang,Haile Qiu,Gehong Zhang,Jing Liu,Enwei Xu,Ruyi Shi,Yanyan Zhang,Haiyan Liu,Chanting He,Zhenxiang Zhao,Yu Qian,Ruizhou Rong,Zhiwei Han,Yanlin Zhang,Wen Luo,Jiaqian Wang,Shaoliang Peng,Xukui Yang,Xiangchun Li,Lin Li,Hu Fang,Xingmin Liu,Li Ma,Yunqing Chen,Shiping Guo,Xing Chen,Yanfeng Xi,Guodong Li,Jianfang Liang,Xiaofeng Yang,Jiansheng Guo,JunMei Jia,Qingshan Li,Xiaolong Cheng,Qimin Zhan,Yongping Cui

DOI: https://doi.org/10.1016/j.ajhg.2015.12.013

2016-01-01

The American Journal of Human Genetics

Abstract:Comprehensive identification of somatic structural variations (SVs) and understanding their mutational mechanisms in cancer might contribute to understanding biological differences and help to identify new therapeutic targets. Unfortunately, characterization of complex SVs across the whole genome and the mutational mechanisms underlying esophageal squamous cell carcinoma (ESCC) is largely unclear. To define a comprehensive catalog of somatic SVs, affected target genes, and their underlying mechanisms in ESCC, we re-analyzed whole-genome sequencing (WGS) data from 31 ESCCs using Meerkat algorithm to predict somatic SVs and Patchwork to determine copy-number changes. We found deletions and translocations with NHEJ and alt-EJ signature as the dominant SV types, and 16% of deletions were complex deletions. SVs frequently led to disruption of cancer-associated genes (e.g., CDKN2A and NOTCH1) with different mutational mechanisms. Moreover, chromothripsis, kataegis, and breakage-fusion-bridge (BFB) were identified as contributing to locally mis-arranged chromosomes that occurred in 55% of ESCCs. These genomic catastrophes led to amplification of oncogene through chromothripsis-derived double-minute chromosome formation (e.g., FGFR1 and LETM2) or BFB-affected chromosomes (e.g., CCND1, EGFR, ERBB2, MMPs, and MYC), with approximately 30% of ESCCs harboring BFB-derived CCND1 amplification. Furthermore, analyses of copy-number alterations reveal high frequency of whole-genome duplication (WGD) and recurrent focal amplification of CDCA7 that might act as a potential oncogene in ESCC. Our findings reveal molecular defects such as chromothripsis and BFB in malignant transformation of ESCCs and demonstrate diverse models of SVs-derived target genes in ESCCs. These genome-wide SV profiles and their underlying mechanisms provide preventive, diagnostic, and therapeutic implications for ESCCs.